Medtronic

NYSE: MDT · Real-Time Price · USD
92.55
0.57 (0.62%)
At close: Aug 15, 2025, 12:46 PM

Medtronic Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020
Net Income
1.06B 1.29B 1.28B 1.04B 654M 1.32B 911M 797M 1.19B 1.23B 436M 929M 1.49B 1.48B 1.32B 769M 1.37B 1.28B 494M 491M
Depreciation & Amortization
840M 684M 675M 662M 654M 649M 672M 672M 679M 679M 671M 668M 688M 672M 676M 671M 684M 678M 671M 669M
Stock-Based Compensation
89M 98M 159M 83M 90M 84M 146M 73M 75M 81M 137M 62M 72M 78M 140M 69M 69M 65M 140M 70M
Other Working Capital
147M 115M 1.36B -194M 140M 1M -582M 96M 729M -261M 538M -311M 379M -35M -88M -321M -648M -303M 15M -142M
Other Non-Cash Items
327M 172M -2.03B 16M 707M 123M 63M -763M 107M 47M 53M 189M 55M -23M 33M 646M 115M 66M 401M 105M
Deferred Income Tax
-235M -138M -31M 88M -258M -214M -36M 919M -148M 14M -74M -18M -370M -156M -67M -11M -214M -139M -72M 3M
Change in Working Capital
450M 462M 905M -905M 924M 510M -1.09B -823M 558M -475M -301M -749M 120M 173M -330M -852M -275M 407M 227M -1.06B
Operating Cash Flow
2.53B 2.57B 958M 986M 2.78B 2.47B 661M 875M 2.46B 1.57B 922M 1.08B 2.06B 2.23B 1.77B 1.29B 1.75B 2.36B 1.86B 278M
Capital Expenditures
-459M -476M -404M -520M -426M -346M -461M -354M -378M -332M -323M -426M -389M -330M -271M -378M -377M -363M -281M -334M
Cash Acquisitions
n/a -98M n/a n/a -137M -52M -22M n/a n/a n/a -676M -1.19B n/a n/a -91M n/a -18M -606M -370M -606M
Purchase of Investments
-2.13B -2.07B -2.14B -1.88B -2.33B -2.02B -1.49B -1.92B -2.04B -1.73B -1.86B -1.88B -1.96B -2.61B -2.66B -2.65B -2.36B -4.09B -3.31B -2.04B
Sales Maturities Of Investments
2.24B 1.92B 2.18B 2.16B 2.3B 1.81B 1.59B 1.75B 1.96B 1.78B 1.72B 1.89B 2.56B 2.49B 2.31B 2.32B 4.59B 2.42B 1.93B 2.4B
Other Investing Acitivies
-138M -112M 18M -17M -106M -96M -42M -17M -11M -4M -11M 30M 61M 8M -3M -76M 82M -132M 12M 590M
Investing Cash Flow
-490M -843M -345M -259M -696M -707M -424M -539M -475M -287M -1.15B -1.58B 271M -437M -709M -784M 1.92B -2.77B -2.02B 8M
Debt Repayment
n/a -1B 557M 2.58B 63M -311M 821M 500M -3.85B -496M 3.78B -27M n/a n/a n/a -1M -3.77B -369M 806M 2.76B
Common Stock Repurchased
-274M -181M -288M -2.49B -1.63B -132M -226M -152M -97M -71M -141M -336M -1.41B -394M -429M -315M -575M -9M -68M n/a
Dividend Paid
-897M -897M -897M -898M -913M -917M -918M -918M -905M -904M -904M -903M -843M -847M -847M -846M -782M -781M -780M -778M
Other Financial Acitivies
-280M 160M -49M -15M 41M -140M 161M 69M -133M -719M 170M 273M 215M -6M -42M -4M -4M -34M -19M -51M
Financial Cash Flow
-1.34B -1.75B -534M -731M -2.36B -1.5B -90M -501M -4.89B -2.13B 3.01B -950M -1.95B -1.18B -1.16B -1.05B -5.13B -998M 32M 1.96B
Net Cash Flow
978M -154M 83M 27M -339M 312M -28M -204M -2.98B -307M 2.69B -1.57B 235M 579M -104M -589M -1.48B -1.34B -79M 2.36B
Free Cash Flow
2.07B 2.1B 554M 466M 2.35B 2.13B 200M 521M 2.08B 1.24B 599M 657M 1.67B 1.9B 1.5B 914M 1.37B 1.99B 1.58B -56M